Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Merck's new integrin receptor antagonists for thrombosis, osteoporosis, atherosclerosis

Nov. 24, 2000

Avigen and Bayer collaborate to bring Coagulin-B to market

Nov. 24, 2000

ACUTE II results presented at AHA sessions

Nov. 23, 2000

Baxter's new recombinant hemophilia therapy enters phase III

Nov. 23, 2000

FDA approves Lovenox for seventh indication

Nov. 22, 2000

S-18886 improves endothelial function in CAD patients

Nov. 21, 2000

Direct factor Xa inhibitor FXV-673 shows good results versus heparin

Nov. 21, 2000

Novel thrombin inhibitor prodrugs for oral administration

Nov. 20, 2000

Genzyme Transgenics reacquires rights to rhATIII

Nov. 17, 2000

SmithKline Beecham launches Argatroban in U.S.

Nov. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...